CRC has an immunosuppressive TME which prevents the event of a successful reaction to ICB therapies. There is thus an urgent really need to determine the methods reprogram this suppressive TME to be able to enhance immunotherapy efficacy. In The existing analyze, we applied CRISPR KO screens to find genes https://michaelm419chm2.wikiap.com/user